Latest Insider Trading Transactions
Page: < prev 1 ... 660 661 662 663 664 665 666 667 667 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2021 | X | UNITED STATES STEE ... | Grewal Manpreet | VP, Controller & CA ... | Payment of Exercise | F | 23.39 | 1,901 | 44,464 | 25,727 | 27.6 K to 25.7 K (-6.88 %) |
Apr 30 2021 | CBNK | Capital Bancorp In ... | Levitt Randall James | Director | Sell | S | 22.28 | 29,700 | 661,716 | 144,500 | 174.2 K to 144.5 K (-17.05 %) |
Apr 30 2021 | NYSE/TRN | TRINITY INDUSTRIES ... | Boze Brandon B | Director | Sell | D | 27.47 | 8,100,000 | 222,507,000 | 15,005,855 | 23.1 M to 15 M (-35.06 %) |
Apr 30 2021 | SPEX | AIkido Pharma Inc. | Hayes Anthony | CEO | Buy | P | 0.99 | 10,000 | 9,900 | 68,430 | 58.4 K to 68.4 K (+17.11 %) |
Apr 30 2021 | EAR | Eargo, Inc. | Pardo Geoff | Director | Sell | S | 57.56 | 27,965 | 1,609,665 | 3,123,222 | 3.2 M to 3.1 M (-0.89 %) |
Apr 30 2021 | EAR | Eargo, Inc. | Pardo Geoff | Director | Sell | S | 56.60 | 44,853 | 2,538,680 | 3,151,187 | 3.2 M to 3.2 M (-1.40 %) |
Apr 30 2021 | EAR | Eargo, Inc. | Pardo Geoff | Director | Sell | S | 55.82 | 16,753 | 935,152 | 3,196,040 | 3.2 M to 3.2 M (-0.52 %) |
Apr 30 2021 | EAR | Eargo, Inc. | Pardo Geoff | Director | Sell | S | 54.82 | 5,898 | 323,328 | 3,212,793 | 3.2 M to 3.2 M (-0.18 %) |
Apr 30 2021 | EAR | Eargo, Inc. | Pardo Geoff | Director | Sell | S | 55.66 | 20,513 | 1,141,754 | 3,218,691 | 3.2 M to 3.2 M (-0.63 %) |
Apr 30 2021 | EAR | Eargo, Inc. | Pardo Geoff | Director | Sell | S | 54.83 | 47,911 | 2,626,960 | 3,239,204 | 3.3 M to 3.2 M (-1.46 %) |
Apr 30 2021 | EAR | Eargo, Inc. | Pardo Geoff | Director | Sell | S | 54.08 | 20,335 | 1,099,717 | 3,287,115 | 3.3 M to 3.3 M (-0.61 %) |
Apr 30 2021 | BHGE | Baker Hughes Co | GENERAL ELECTRIC CO | Director | Sell | S | 22.23 | 43,685,723 | 971,133,622 | 0 | 43.7 M to 0 (-100.00 %) |
Apr 30 2021 | GE | GENERAL ELECTRIC C ... | GENERAL ELECTRIC CO | Director | Sell | S | 22.23 | 43,685,723 | 971,133,622 | 0 | 43.7 M to 0 (-100.00 %) |
Apr 30 2021 | JMP | JMP GROUP LLC | WEDBUSH SECURITIES INC | 10% Owner | Buy | P | 6.64 | 600 | 3,981 | 2,098,600 | 2.1 M to 2.1 M (+0.03 %) |
Apr 30 2021 | JMP | JMP GROUP LLC | WEDBUSH SECURITIES INC | 10% Owner | Buy | P | 6.64 | 600 | 3,981 | 2,098,600 | 2.1 M to 2.1 M (+0.03 %) |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | MOTT RICHARD W | Director | Option Exercise | C | 0.00 | 699,141 | 0 | 0 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | MOTT RICHARD W | Director | Option Exercise | J | 0.00 | 16,180 | 0 | 699,141 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | MOTT RICHARD W | Director | Buy | C | 0.00 | 699,141 | 0 | 1,697,705 | 998.6 K to 1.7 M (+70.01 %) |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Hair Mark | Chief Financial Off ... | Buy | P | 17.00 | 3,600 | 61,200 | 3,600 | 0 to 3.6 K |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Hair Mark | Chief Financial Off ... | Buy | P | 17.00 | 10,000 | 170,000 | 10,000 | 0 to 10 K |
Apr 29 2021 | SPWR | SUNPOWER CORP | Sial Manavendra | EVP and CFO | Option Exercise | A | 0.00 | 2,491 | 0 | 2,491 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | TREACE JOHN R | Director | Option Exercise | C | 0.00 | 427,875 | 0 | 0 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | TREACE JOHN R | Director | Option Exercise | J | 0.00 | 9,906 | 0 | 9,906 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | TREACE JOHN R | Director | Sell | S | 17.00 | 401,250 | 6,821,250 | 2,306,606 | 2.7 M to 2.3 M (-14.82 %) |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | TREACE JOHN R | Director | Buy | C | 0.00 | 427,875 | 0 | 2,707,856 | 2.3 M to 2.7 M (+18.77 %) |
Apr 29 2021 | PCCC | PC CONNECTION INC | GALLUP PATRICIA | Chairman & Chief Ad ... | Sell | Z | 0.00 | 250,000 | 0 | 7,119,094 | 7.4 M to 7.1 M (-3.39 %) |
Apr 29 2021 | PCCC | PC CONNECTION INC | GALLUP PATRICIA | Chairman & Chief Ad ... | Buy | Z | 0.00 | 250,000 | 0 | 463,217 | 213.2 K to 463.2 K (+117.25 %) |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | SVP, Research & Dev ... | Option Exercise | C | 0.00 | 342,300 | 0 | 0 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | SVP, Research & Dev ... | Option Exercise | J | 0.00 | 7,925 | 0 | 342,300 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | SVP, Research & Dev ... | Buy | C | 0.00 | 342,300 | 0 | 342,300 | 0 to 342.3 K |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 713,064 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 5,162,969 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 995,714 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,206,216 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,073,308 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,772,634 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,605,711 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,628,174 | 0 | 0 | |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 69,380 | 1,040,700 | 349,674 | 280.3 K to 349.7 K (+24.75 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 505,620 | 7,584,300 | 2,535,115 | 2 M to 2.5 M (+24.91 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 13.50 | 12,311 | 166,199 | 280,294 | 268 K to 280.3 K (+4.59 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 13.50 | 89,145 | 1,203,458 | 2,029,495 | 1.9 M to 2 M (+4.59 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 43,550 | 0 | 267,983 | 224.4 K to 268 K (+19.40 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 315,328 | 0 | 1,940,350 | 1.6 M to 1.9 M (+19.40 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 60,813 | 0 | 224,433 | 163.6 K to 224.4 K (+37.17 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 440,119 | 0 | 1,625,022 | 1.2 M to 1.6 M (+37.14 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 65,552 | 0 | 163,620 | 98.1 K to 163.6 K (+66.84 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 474,713 | 0 | 1,184,903 | 710.2 K to 1.2 M (+66.84 %) |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 98,068 | 0 | 98,068 | 0 to 98.1 K |
Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 710,190 | 0 | 710,190 | 0 to 710.2 K |
Apr 29 2021 | PCCC | PC CONNECTION INC | HALL DAVID | Sell | Z | 0.00 | 250,000 | 0 | 0 | 250 K to 0 (-100.00 %) | |
Apr 29 2021 | PCCC | PC CONNECTION INC | HALL DAVID | Buy | Z | 0.00 | 250,000 | 0 | 0 | -250,000 to 0 (-100.00 %) | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Frias Jaime A. | See Remarks | Option Exercise | C | 0.00 | 42,785 | 0 | 0 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Frias Jaime A. | See Remarks | Option Exercise | C | 0.00 | 85,570 | 0 | 0 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Frias Jaime A. | See Remarks | Option Exercise | J | 0.00 | 988 | 0 | 42,785 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Frias Jaime A. | See Remarks | Option Exercise | J | 0.00 | 1,976 | 0 | 85,570 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Frias Jaime A. | See Remarks | Sell | S | 17.00 | 329,230 | 5,596,910 | 42,786 | 372 K to 42.8 K (-88.50 %) |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Frias Jaime A. | See Remarks | Buy | C | 0.00 | 42,785 | 0 | 372,016 | 329.2 K to 372 K (+13.00 %) |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | Frias Jaime A. | See Remarks | Buy | C | 0.00 | 85,570 | 0 | 225,551 | 140 K to 225.6 K (+61.13 %) |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | TREACE JAMES T | Director | Option Exercise | C | 0.00 | 569,067 | 0 | 0 |
Page: < prev 1 ... 660 661 662 663 664 665 666 667 667 next >